business The Hindu
Wednesday, September 2, 2026
Source: The Hindu
Verified Coverage
Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes
The U.S. is the company’s largest market for innovative medicines and a cornerstone of its long-term growth strategy, generating approximately 27% of the company’s global revenue.
Source: The Hindu
Read Complete Story at Source
This report is aggregated by Public News Express. Click below to view full original reporting directly on The Hindu.
Visit The Hindu
